Clinical Trial Update: A Phase II Randomized Open Label Study of KLH-2109 in Patients With Endometriosis [Phase 2]

View source ↗

Summary

A Phase II randomized open-label study evaluating KLH-2109 for endometriosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• KLH-2109

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Endometriosis | Phase 2 | Status: COMPLETED